The International Partnerships in Ice Core Sciences (IPICS) Second Open Science Conference has begun. [ + ]

Prime Minister Malcolm Turnbull has announced the imminent expansion of The University of Melbourne's Bio21 Molecular Science and Biotechnology Institute. [ + ]

Researchers from the Walter and Eliza Hall Institute have discovered a protein that is key to the development of blood cancers caused by a common genetic error. [ + ]

Queensland Premier Annastacia Palaszczuk last week opened the TRI Innovation and Translation Centre in collaboration with Siemens Healthcare. Based at Princess Alexandra Hospital, it is said to be the second facility of its kind in the world. [ + ]

Researchers claim that a previously undiscovered mechanism in a key group of neurons affected in a neurodegenerating brain is the driver of the continuing cycle of neuronal cell death. [ + ]

Comprehensive data on the European bioeconomy — that is, those parts of the economy that use renewable biological resources from land and sea to produce food, materials and energy — has been released for the first time. [ + ]

Clinical Genomics has received China Food and Drug Administration approval for the commercialisation of InSure FIT, its faecal immunochemical test for colorectal cancer. [ + ]

A five-year research project into personalised medicine for common diseases has been awarded $7 million by the National Health and Medical Research Council. [ + ]

Two key players in the fight against prostate cancer have announced that they will work together to fund and implement vital clinical trials into the disease. [ + ]

A research team has found that treatment of acute myeloid leukaemia — the most deadly form of blood cancer — may be improved by combining two recently developed drugs. [ + ]

Christopher Pyne has announced the five-year appointment of physicist Professor Tanya Monro to the CSIRO board. [ + ]

Adelaide biotechnology company TGR BioSciences has received its second US patent in six months, covering key aspects of the company's CaptSure immunoassay technology. [ + ]

Scientists from the California Institute of Technology have invented a technique that will help bring emerging diagnostic capabilities out of laboratories and to the point of care. [ + ]

ide Group will be awarding $25,000 worth of product design and development support for the best health innovation product idea pitched at Building Better Futures for Health: A Product Design Challenge. [ + ]

ImmunID, a French company that seeks to personalise immunotherapy for cancer patients, has signed a master collaboration agreement with the world's oldest and largest private cancer centre. [ + ]